AMLX: Amylyx Pharmaceuticals, Inc. Company Short-Term Debt
Amylyx Pharmaceuticals (AMLX) is revising its development portfolio, investing liquidity into the search for new molecules to combat rare genetic disorders. This price chart on the GURU.Markets platform reflects the asset's dynamics, with a metric of 0.00. The business currently lacks pricing power due to failures with its primary drug, which has triggered a large-scale structural reorganization. Meanwhile, the company is relying on partnerships with scientists and patient communities to develop neurodegeneration therapies.
Analytical breakdowns and data insights for company Amylyx Corp (AMLX)
- current quotes and average value forecast:
- market capitalization information:
- shareholders' equity book value data:
- debt and liquidity details:
Total Debt to Equity Ratio Amylyx Pharmaceuticals|AMLX - Long-Term Liabilities to Capital|Short-Term Debt to Equity Amylyx Pharmaceuticals|AMLX - Company Debts|Debt to Book Value Amylyx Pharmaceuticals, Inc.|AMLX - Long-Term Debt|Company Current Liabilities Amylyx Pharmaceuticals|Quick Liquidity Indicator amylyx.com
- net income and valuation multiples indicators:
Fundamental company valuation:Amylyx Pharmaceuticals, Inc. - AMLX
This indicator captures total liabilities maturing within one year, determining the risk of liquidity loss. By analyzing short-term financial debts with a maturity of up to one year, an investor assesses the issuer's ability to service current loans. For Amylyx Pharmaceuticals (AMLX), this metric is critical due to the uncertainty of future revenues following the market recall of its drug. A high debt load amid unstable flows could trigger a cash crunch, rendering the asset high-risk.
Main competitors
BIIB - Company Short-Term Debt|Company Short-Term Loans and Borrowings NBIX (Neurocrine)|Regencell (RGC) - Company Short-Term Debt|Short-Term Debt Axsome Corp (AXSM)|ACAD (ACADIA Pharmaceuticals) - Company Short-Term Debts|Company Short-Term Debts xenon-pharma.com|Company Short-Term Debt Viking Therapeutics, Inc. (VKTX)|Company Current Liabilities Supernus Pharmaceuticals, Inc. SUPN|Catalyst Pharmaceuticals Inc - Company Current Liabilities|Denali Corp (DNLI) - Short-Term Debt|HRMY - Company Short-Term Debt|BHVN: Company Short-Term Debt|TRVI (Trevi Therapeutics, Inc.) - Company Current Liabilities|Short-Term Debt Praxis Precision Medicines Inc (PRAX)|Company Current Liabilities AVXL|Company Short-Term Indebtedness CBLL (CeriBell EEG)|Company Current Liabilities PRTA (Prothena)|ALEC (alector.com) - Company Short-Term Loans and Borrowings|Company Short-Term Debt Annexon ANNX|OMER (Omeros Corp) - Current Liabilities|Neurogene Corp - Company Short-Term Debts|Company Short-Term Loans and Borrowings ACIU (AC Immune Inc)|VYGR: Company Short-Term Debts|neumoratx.com (NMRA) - Company Short-Term Debts|Company Short-Term Debt Scilex|TVGN: Company Short-Term Loans and Borrowings|Company Short-Term Debt Alpha Cognition (ACOG)|Company Current Liabilities cogrx.com CGTX|Company Short-Term Debts IKT (Inhibikase Therapeutics)|Company Short-Term Debts cassavasciences.com SAVA|Assertio Therapeutics - Company Short-Term Debts|Coya Therapeutics, Inc. (COYA) - Company Current Liabilities|VTGN: Company Short-Term Debts|Short-Term Debt Ovid Therapeutics (OVID)|Company Current Liabilities ABOS|Company Short-Term Debts cervomed.com|Company Current Liabilities ATHE (Alterity Therapeutics)|Amount of Current Liabilities CLNN|Company Short-Term Debts PEPG (PepGen)|Short-Term Debt Volume jupiterneurosciences.com (JUNS)|Relmada Therapeutics - Company Short-Term Debts|annovisbio.com (ANVS) - Company Current Liabilities|GRCE: Company Short-Term Debts|Firefly Neuroscience, Inc. (AIFF) - Company Short-Term Debts|Company Short-Term Debt ANEW Medical|Company Short-Term Debt NRSN|Company Short-Term Debt Reviva Pharmaceuticals (RVPH)|Short-Term Debt Volume metaviatx.com|Company Short-Term Debts NRXS (NeurAxis)|Company Short-Term Debts Helius Medical Technologies, Inc. HSDT|PASG - Company Short-Term Debt|Neuphoria Therapeutics Inc. (NEUP) - Company Current Liabilities|Minerva Neurosciences (NERV) - Company Short-Term Debt|ATHA (athira.com) - Company Short-Term Debt|Company Current Liabilities ADXN|Company Short-Term Indebtedness ALZN (Alzamend)|Company Short-Term Debt Cyclerion Therapeutics (CYCN)|protagenic.com - Company Short-Term Indebtedness|Company Short-Term Debts KTTA (Pasithea Therapeutics Corp.)|Cortigent Inc (CRGT) - Short-Term Debt|ATXI: Company Current Liabilities|BCLI - Company Short-Term Debts|Cara Therapeutics, Inc (CARA) - Company Short-Term Debt|Chromocell - Company Short-Term Loans and Borrowings|Company Short-Term Debt Eliem Therapeutics, Inc.|Short-Term Debt Intra-Cellular ITCI|Company Short-Term Debts LBPH|Company Short-Term Debts Marinus Pharmaceuticals Inc (MRNS)|Company Short-Term Debt NKGen NKGN|NRBO - Company Current Liabilities|SAGE: Company Current Liabilities|Short-Term Debt synaptogen.com|Trevena (TRVN) - Company Short-Term Debt|VIGL (Vigil Neuroscience, Inc.) - Company Short-Term Debt|Company Current Liabilities WENA|Short-Term Debt Cerevel Corp CERE